<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://kyforabio.com/blogs/news/upstream-aav-manufacturing-process-challenges</loc>
    <lastmod>2026-02-16T09:35:55-05:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/make-a-photorealistic-image-of-a-bioreactor-instead.png?v=1771252555</image:loc>
      <image:title>Navigating Upstream AAV Manufacturing Process Challenges in Next-Gen Bioprocessing</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://kyforabio.com/blogs/news/polyethylenimine-pei-transfection-protocol-optimization</loc>
    <lastmod>2025-12-16T07:05:06-05:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/photorealistic-image-of-pei-transfection-reagent-in-use.png?v=1765886706</image:loc>
      <image:title>Polyethylenimine (PEI) Transfection Protocol Optimization: Dos and Don’ts for High Efficiency</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://kyforabio.com/blogs/news/cell-and-gene-therapies-regulatory-strategy-across-the-us-and-eu</loc>
    <lastmod>2026-03-06T10:37:43-05:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/AdobeStock_1196369082_copy.jpg?v=1772811463</image:loc>
      <image:title>Approved Cell and Gene Therapies: Regulatory Strategy Across the US and EU</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://kyforabio.com/blogs/news/smashgene%E2%84%A2-sets-a-new-standard-in-transfection-higher-titers-without-the-complexity-or-cost-of-competitor-reagents</loc>
    <lastmod>2026-06-02T10:23:48-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/Amplifect_GMP_02_1800_3_82d5eaca-fa4e-4eaa-b968-8901e2e48d5e.png?v=1780410228</image:loc>
      <image:title>SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://kyforabio.com/blogs/news/how-to-evaluate-transfection-reagents-in-viral-vector-production-workflows</loc>
    <lastmod>2026-08-12T11:59:14-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/Designer.png?v=1786550354</image:loc>
      <image:title>How to Evaluate Transfection Reagents in Viral Vector Workflows</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://kyforabio.com/blogs/news/residual-testing-in-viral-vector-manufacturing-why-it-matters</loc>
    <lastmod>2026-08-13T13:11:19-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0855/9748/7393/articles/Beige_and_Black_Simple_Minimalist_Company_Organizational_Chart_Graph_eac3b3ee-f8f4-4896-847d-4469ab957884.png?v=1786641079</image:loc>
      <image:title>Residual Testing in Viral Vector Manufacturing: Why It Matters</image:title>
    </image:image>
  </url>
</urlset>
